Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Levetiracetam and Memory Loss

View through CrossRef
Epilepsy is defined as a chronic disorder that causes a sudden rush of electrical activities in the brain. These seizures may be partial or general. While fractional annexations affect a solitary part of the brain, comprehensive seizures distress the entire brain and its activities. There exist myriad options for seizure treatment. Use of Keppra, the brand name for Levetiracetam, is one of the most adopted forms of treatment. These seizures are generally caused by low blood sugar, alcohol withdrawal as well as head trauma. For one to be prescribed seizure drugs, signs such as simple partial seizures, complex partial seizures as well as general seizures must be present. There are other options for managing seizures such as brain surgery, adopting a Ketogenic diet and anti-epileptic drugs. Levetiracetam is typically prescribed as an add-on to these seizure drugs to boost their effectiveness and as well ensure improved quality of life. While essential resources and information are recommending the use of Levetiracetam, there are also sources discrediting the drug with evidence of causing memory loss and reduced quality of life. Therefore, this study aims at collecting information from different scholarly articles, journals, and websites about the side effects of using Levetiracetam in different populations. After the data is explored, the study offers a comprehensive conclusion based on the information available. The study, therefore, affirms that the use of Levetiracetam improves the quality of life and it does not affect or interfere with the cognitive functions of the brain. The study seeks to demystify the linking of Levetiracetam to memory loss of its users.
Title: Levetiracetam and Memory Loss
Description:
Epilepsy is defined as a chronic disorder that causes a sudden rush of electrical activities in the brain.
These seizures may be partial or general.
While fractional annexations affect a solitary part of the brain, comprehensive seizures distress the entire brain and its activities.
There exist myriad options for seizure treatment.
Use of Keppra, the brand name for Levetiracetam, is one of the most adopted forms of treatment.
These seizures are generally caused by low blood sugar, alcohol withdrawal as well as head trauma.
For one to be prescribed seizure drugs, signs such as simple partial seizures, complex partial seizures as well as general seizures must be present.
There are other options for managing seizures such as brain surgery, adopting a Ketogenic diet and anti-epileptic drugs.
Levetiracetam is typically prescribed as an add-on to these seizure drugs to boost their effectiveness and as well ensure improved quality of life.
While essential resources and information are recommending the use of Levetiracetam, there are also sources discrediting the drug with evidence of causing memory loss and reduced quality of life.
Therefore, this study aims at collecting information from different scholarly articles, journals, and websites about the side effects of using Levetiracetam in different populations.
After the data is explored, the study offers a comprehensive conclusion based on the information available.
The study, therefore, affirms that the use of Levetiracetam improves the quality of life and it does not affect or interfere with the cognitive functions of the brain.
The study seeks to demystify the linking of Levetiracetam to memory loss of its users.

Related Results

Efficacy Of Phentoin Versus Levetiracetam In Children Presenting With Status Epilepticus At Tertiary Care Hospital Quetta
Efficacy Of Phentoin Versus Levetiracetam In Children Presenting With Status Epilepticus At Tertiary Care Hospital Quetta
Objectives: To assess and evaluate how well Phenytoin performs in treating status epilepticus as compared to Levetiracetam, in children at a tertiary care hospital in Quetta. Study...
Levetiracetam-induced Rhabdomyolysis - A Rare Complication
Levetiracetam-induced Rhabdomyolysis - A Rare Complication
Background: Levetiracetam is an anti-epileptic drug that works by modulation of synaptic neurotransmitter release through binding to the synaptic vesicle protein 2A. Levetiracetam ...
Efficacy and Safety of Using Levetiracetam and Phenobarbitone for the Treatment of Neonatal Seizure due to Hypoxic Ischemic Encephalopathy
Efficacy and Safety of Using Levetiracetam and Phenobarbitone for the Treatment of Neonatal Seizure due to Hypoxic Ischemic Encephalopathy
Background: Timely diagnosis and management of a patient of neonatal seizure are challenging due to limited resources and adverse effects produced by the drugs used. Phenobarbitone...
Assessment of knowledge and practice of pediatric residents towards using and efficacy of levetiracetam as treatment for neonatal seizure
Assessment of knowledge and practice of pediatric residents towards using and efficacy of levetiracetam as treatment for neonatal seizure
Background: Seizures are a common neurologic complication in neonates, with severity ranging from mild to life-threatening. Despite their prevalence, clinical management guidelines...
A Suspected Case of Levetiracetam Induced Rhabdomyolysis
A Suspected Case of Levetiracetam Induced Rhabdomyolysis
Abstract Background: Levetiracetam is a broad-spectrum antiseizure drug which works to terminate convulsions and is used in the treatment of certain types of seizures. It is common...
Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy
Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy
Summary Purpose: A multicenter, prospective, long‐term, open‐label study to evaluate the effects of levetiracetam on electroencephalogram (EEG) abnormalities and photo...
COMPARATIVE EFFICACY OF LEVETIRACETAM AND SODIUM VALPROATE IN THE TREATMENT OF EARLY CHILDHOOD EPILEPSY
COMPARATIVE EFFICACY OF LEVETIRACETAM AND SODIUM VALPROATE IN THE TREATMENT OF EARLY CHILDHOOD EPILEPSY
Background: Epilepsy is among the most common chronic neurological disorders in children, with considerable impact on cognitive and psychosocial development. Sodium valproate is a ...

Back to Top